NEW YORK, January 25, 2016—Kantar Health, a leading global healthcare consulting and market research firm, today announced that Stephen Potts has been named Managing Director of Kantar Health UK. In this role, Potts will combine Kantar Health's broad portfolio of services to support healthcare companies across Europe as they seek to launch and grow their brands successfully.
“The pharmaceutical and healthcare industries are of huge importance in the UK, working with the government to ensure health priorities are met and patient outcomes are improved, so it was vital that we have someone with in-depth knowledge and experience within this market to further our contributions,” said Michel Murino, CEO, Kantar Health Europe. “Stephen has rich expertise in the UK and across Europe and has developed and grown teams that give our healthcare clients the insights they need to successfully meet patients’ needs.”
Potts returns to Kantar Health, where he held a series of positions with increasing responsibilities. Most recently he served as Managing Director – Asia Pacific, Middle East and Africa with Kantar Health and was instrumental in the launch of Kantar Health in 2009.
“I began my career in Kantar Health’s UK office, and I’m excited to be coming home,” Potts said. “Kantar Health has a robust tradition of leading innovations in market research, branding and customer experience and leads our industry in data visualization. I’m thrilled to be rejoining this creative, forward-looking team and working with our clients to help them improve patients’ lives.”
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. Kantar Health is part of Kantar, the data investment management division of WPP. For more information, please visit www.kantarhealth.com.